Clinical Trials Browser

Phase 3 × Recurrence × Sorafenib × Clear all

NCT02867280 2020-02-11

Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence